1. Home
  2. PBYI vs TWIN Comparison

PBYI vs TWIN Comparison

Compare PBYI & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • TWIN
  • Stock Information
  • Founded
  • PBYI 2010
  • TWIN 1918
  • Country
  • PBYI United States
  • TWIN United States
  • Employees
  • PBYI N/A
  • TWIN N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • TWIN Industrial Machinery/Components
  • Sector
  • PBYI Health Care
  • TWIN Industrials
  • Exchange
  • PBYI Nasdaq
  • TWIN Nasdaq
  • Market Cap
  • PBYI 176.1M
  • TWIN 169.9M
  • IPO Year
  • PBYI N/A
  • TWIN N/A
  • Fundamental
  • Price
  • PBYI $2.59
  • TWIN $12.28
  • Analyst Decision
  • PBYI Strong Buy
  • TWIN
  • Analyst Count
  • PBYI 1
  • TWIN 0
  • Target Price
  • PBYI $7.00
  • TWIN N/A
  • AVG Volume (30 Days)
  • PBYI 345.1K
  • TWIN 25.3K
  • Earning Date
  • PBYI 10-31-2024
  • TWIN 10-31-2024
  • Dividend Yield
  • PBYI N/A
  • TWIN 1.26%
  • EPS Growth
  • PBYI N/A
  • TWIN 5.33
  • EPS
  • PBYI 0.18
  • TWIN 0.79
  • Revenue
  • PBYI $219,143,000.00
  • TWIN $295,127,000.00
  • Revenue This Year
  • PBYI N/A
  • TWIN N/A
  • Revenue Next Year
  • PBYI N/A
  • TWIN N/A
  • P/E Ratio
  • PBYI $13.90
  • TWIN $16.09
  • Revenue Growth
  • PBYI N/A
  • TWIN 6.56
  • 52 Week Low
  • PBYI $2.13
  • TWIN $10.90
  • 52 Week High
  • PBYI $7.73
  • TWIN $18.00
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 45.60
  • TWIN 45.81
  • Support Level
  • PBYI $2.23
  • TWIN $11.50
  • Resistance Level
  • PBYI $2.42
  • TWIN $12.37
  • Average True Range (ATR)
  • PBYI 0.15
  • TWIN 0.47
  • MACD
  • PBYI 0.05
  • TWIN -0.06
  • Stochastic Oscillator
  • PBYI 76.60
  • TWIN 38.86

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its products portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: